| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |